Graves' Disease Remission Study: MycoMeth Combo

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Graves' Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Xiao Fangsen, Xiamen, Fujian, China
Contact: Study coordinator (Fangsen Xiao, MD) · xfs888@163.com · +8613859955389
Contact: Study coordinator (Liyin Wang, MM) · wlywly1979@163.com · +8613950139047

Study leads

Fangsen Xiao, MD
Principal Investigator
The first affiliated hospital of Xiamen University Medical College

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves' Disease

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Phoenix, United States

A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

Graves' Disease

Abroad (travel likely)RecruitingPHASE2

Calgary, Canada · Surrey, Canada

In Vivo CAR-T for Refractory Graves' Disease

Graves' Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease

Graves Disease · Relapse · Treatment

Abroad (travel likely)RecruitingPHASE4

Nanjing, China